LUX Infusion Expands Its Northeast Operations with New Acquisitions in New Jersey and New York

LUX Infusion Strengthens Northeast Presence Through Strategic Acquisitions

In a significant move to expand its footprint in the Northeast, LUX Infusion, a clinician-led infusion services company, has acquired two ambulatory infusion centers. The newly acquired centers are the South Jersey Pediatric and Adult Infusion Center, located in Cherry Hill, New Jersey, and Northeast Infusion Therapy in Latham, New York. This acquisition is a testament to LUX Infusion's commitment to improving access to high-quality infusion care in supportive and clinically supervised environments.

Both centers are known for their established local care models focusing on patient comfort and collaboration with healthcare providers. The South Jersey Pediatric and Adult Infusion Center specializes in providing physician-ordered infusion services designed for both pediatric and adult patients in a comfortable outpatient setting. Emphasizing medical supervision and patient comfort, the center ensures proper coordination with referring physicians to support seamless patient care.

On the other hand, the Northeast Infusion Therapy center caters specifically to adults living with chronic diseases, providing medically prescribed infusion services in a private and friendly atmosphere. Northeast Infusion Therapy places a strong emphasis on treatment coordination and support with documentation and prior authorizations.

According to Ted Kramm, the Chief Executive Officer of LUX Infusion, the primary goal of this acquisition is to enhance accessibility to complex infusion care. He stated, "Our focus has always been on making complex infusion care easier to access and easier to navigate for patients, providers, and families. South Jersey Pediatric and Adult Infusion Center and Northeast Infusion Therapy share that commitment, and we are proud to welcome them to LUX Infusion as we continue expanding our clinician-led AIC model of care."

This expansion enables LUX Infusion to join a growing network that prioritizes coordinated therapy access and improved patient experiences. As part of the integration process, LUX Infusion plans to work closely with the teams at both centers to maintain continuity for patients during the transition.

LUX Infusion is recognized for delivering high-quality, coordinated care focused on patients who depend on complex infusion therapies. As a portfolio company of Frazier Healthcare Partners, LUX Infusion aims to enhance its operations and offerings through strategic acquisitions.

About LUX Infusion

LUX Infusion stands out as a leading infusion services provider in the U.S., with a commitment to clinical expertise and superior patient experiences. As they continue to grow their national network, the company positions itself to better serve patients, healthcare providers, payors, and manufacturing partners. For more information, visit www.luxinfusion.com and follow them on Facebook and LinkedIn.

Media Contact

For further inquiries about LUX Infusion's services or the recent acquisitions, please reach out to Tara Marchese, Senior Director of Marketing, at 954-908-7636 or via email at [email protected].